CancerX, a new initiative under President Joe Biden’s Cancer Moonshot, looks to bring diverse stakeholders together to leverage digital technology to tackle the biggest challenges in cancer
Dr Gen Li, founder and president of Phesi, a provider of AI-powered clinical development analytics, products, and solutions, discusses ASCO, digital patient profiles, and how digital twins
Tumour survival, growth, and proliferation demand complex and broad biological capabilities, including proliferative signalling, evasion of growth suppressors, promotion of local blood vess
AstraZeneca has upgraded a 2020 alliance with Fusion Pharma focusing on radioconjugate therapies for cancer, opting to buy the firm outright in a deal worth around $2 bill
Today, pharma brand planning teams can benefit from technology platforms that aggregate data and automate analyses, helping unlock insights on the market landscape and clinical environment